{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:56:21Z","timestamp":1767999381062,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cjca.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T03:31:13Z","timestamp":1503113473000},"page":"1597-1603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anticoagulation for Thromboembolic Risk Reduction in Adults With Congenital Heart Disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Darryl","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla","family":"Kiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santabhanu","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2017.08.009_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12471-012-0335-1","article-title":"Epidemiology of adult congenital heart disease: demographic variations worldwide","volume":"20","author":"Mulder","year":"2012","journal-title":"Neth Heart J"},{"key":"10.1016\/j.cjca.2017.08.009_bib2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2010.03.085","article-title":"Changing mortality in congenital heart disease","volume":"56","author":"Khairy","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12963-015-0063-z","article-title":"Projected growth of the adult congenital heart disease population in the United States to 2050: an integrative systems modeling approach","volume":"13","author":"Benziger","year":"2015","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.cjca.2017.08.009_bib4","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","article-title":"Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre","volume":"132","author":"Diller","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.08.009_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2017.02.004","article-title":"Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias","volume":"234","author":"Masuda","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib6","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/CIRCULATIONAHA.109.866319","article-title":"Atrial arrhythmias in adults with congenital heart disease","volume":"120","author":"Bouchardy","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.08.009_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.04.056","article-title":"Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity","volume":"50","author":"Broberg","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijcard.2014.07.104","article-title":"Acquired von Willebrand syndrome in adult patients with congenital heart disease","volume":"176","author":"Waldow","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2006.01.083","article-title":"Pathogenesis of thrombocytopenia in cyanotic congenital heart disease","volume":"98","author":"Lill","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2015.02.024","article-title":"Weighing the risks: thrombotic and bleeding events in adults with atrial arrhythmias and congenital heart disease","volume":"186","author":"Heidendael","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijcard.2016.08.223","article-title":"Thromboprophylaxis for atrial arrhythmias in congenital heart disease: a multicenter study","volume":"223","author":"Khairy","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.08.009_bib13","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.08.009_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Ravaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.08.009_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.08.009_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjcard.2015.10.062","article-title":"Usefulness of direct oral anticoagulants in adult congenital heart disease","volume":"117","author":"Pujol","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib17","first-page":"1","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"6736","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2017.08.009_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00392-015-0919-z","article-title":"Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves","volume":"105","author":"Yadlapati","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib19","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/CIR.0000000000000204","article-title":"Congenital heart disease in the older adult: a scientific statement from the American Heart Association","volume":"131","author":"Bhatt","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.08.009_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.105.592410","article-title":"Arrhythmias in adult patients with congenital heart disease","volume":"115","author":"Walsh","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.08.009_bib21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.103.5.699","article-title":"Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow \u201cfocal\u201d ablation","volume":"103","author":"Nakagawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.08.009_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0002-9149(02)02480-3","article-title":"Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease","volume":"90","author":"Kirsh","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib23","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/STROKEAHA.113.001118","article-title":"Paroxysmal supraventricular tachycardia and the risk of ischemic stroke","volume":"44","author":"Kamel","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2017.08.009_bib24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/hrt.2010.196147","article-title":"Cerebrovascular accidents in adult patients with congenital heart disease","volume":"96","author":"Hoffmann","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2017.08.009_bib25","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.hrthm.2014.05.009","article-title":"PACES\/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease","volume":"11","author":"Khairy","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2017.08.009_bib26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cjca.2014.09.002","volume":"30","author":"Khairy","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.08.009_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1747-0803.2012.00633.x","article-title":"Does anticoagulation in Eisenmenger syndrome impact long-term survival?","volume":"7","author":"Sandoval","year":"2012","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.cjca.2017.08.009_bib29","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2003.07.022","article-title":"Pulmonary thrombosis in adults with Eisenmenger syndrome","volume":"42","author":"Silversides","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib30","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1136\/hrt.2004.039198","article-title":"Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger's syndrome: a clinical dilemma","volume":"90","author":"Broberg","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2017.08.009_bib31","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1161\/CIRCULATIONAHA.108.190811","article-title":"ACC\/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary","volume":"118","author":"Warnes","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.08.009_bib32","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC guidelines for the management of grown-up congenital heart disease (new version 2010)","volume":"31","author":"Baumgartner","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2017.08.009_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2017.08.009_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.CIR.92.9.287","article-title":"Thromboembolic complications after fontan operations","volume":"92","author":"Rosenthal","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.08.009_bib35","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/heartjnl-2015-307930","article-title":"Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis","volume":"101","author":"Alsaied","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2017.08.009_bib36","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1016\/j.ijcard.2013.06.058","article-title":"Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation","volume":"168","author":"Potter","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0003-4975(02)03677-9","article-title":"Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches","volume":"74","author":"Seipelt","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2017.08.009_bib38","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines [erratum in: 2014;63:2489]","volume":"63","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.08.009_bib39","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus Warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.08.009_bib40","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/eurheartj\/ehu388","article-title":"Transcatheter heart valve failure: a systematic review","volume":"36","author":"Mylotte","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2017.08.009_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.114.001779","article-title":"Treatment and clinical outcomes of transcatheter heart valve thrombosis","volume":"8","author":"Latib","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2017.08.009_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.semperi.2014.04.015","article-title":"Adult congenital heart disease and pregnancy","volume":"38","author":"Rao","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.cjca.2017.08.009_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/OGX.0000000000000190","article-title":"Adult congenital heart disease in pregnancy","volume":"70","author":"Lindley","year":"2015","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.cjca.2017.08.009_bib44","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/eurheartj\/ehx032","article-title":"Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis","volume":"38","author":"D'Souza","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2017.08.009_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","article-title":"Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature","volume":"160","author":"Chan","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2017.08.009_bib46","doi-asserted-by":"crossref","first-page":"1248.e1","DOI":"10.1016\/j.cjca.2015.11.005","article-title":"Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis","volume":"32","author":"Xu","year":"2016","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X17309108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X17309108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T11:54:57Z","timestamp":1535457297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X17309108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0828282X17309108"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2017.08.009","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation for Thromboembolic Risk Reduction in Adults With Congenital Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}